Johnson & Johnson

NYSE

Market Cap.

392.42B

Avg. Volume

9.17M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Johnson & Johnson

Johnson & Johnson News

Johnson & Johnson Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock
Website screenshot
HealthcareDrug Manufacturers - General
jnj.com

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Johnson & Johnson Earnings & Revenue

Johnson & Johnson Financials

Table Compare

Compare JNJ metrics with:

   

Earnings & Growth

JNJ

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

JNJ

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

JNJ

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

JNJ

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Johnson & Johnson Income

Johnson & Johnson Balance Sheet

Johnson & Johnson Cash Flow

Johnson & Johnson Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityBuy
Return on AssetsStrong Buy
Debt/Equity RatioSell
Price/Earnings RatioStrong Sell
Price/Book RatioSell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Johnson & Johnson Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

4.9600

Payment DateDividendFrequency
2025-03-041.24Quarterly
2024-12-101.24Quarterly
2024-09-101.24Quarterly
2024-06-041.24Quarterly
2024-03-051.19Quarterly

Johnson & Johnson Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Historical Market Cap

Shares Outstanding

Johnson & Johnson Executives

NameRole
Mr. Joaquin DuatoChief Executive Officer & Chairman
Ms. Jennifer L. TaubertExecutive Vice President & Worldwide Chairman of Innovative Medicine
Dr. John C. Reed M.D., Ph.D.Executive Vice President of Innovative Medicine, R&D
Ahmet Tezel Ph.D.Group Chairman & Global Head of MedTech Innovation and R&D
Mr. Tom CavanaughCompany Group Chairman for North America Innovative Medicine
NameRoleGenderDate of BirthPay
Mr. Joaquin DuatoChief Executive Officer & ChairmanMale19635.9M
Ms. Jennifer L. TaubertExecutive Vice President & Worldwide Chairman of Innovative MedicineFemale19643.16M
Dr. John C. Reed M.D., Ph.D.Executive Vice President of Innovative Medicine, R&D19583.11M
Ahmet Tezel Ph.D.Group Chairman & Global Head of MedTech Innovation and R&D

--

Mr. Tom CavanaughCompany Group Chairman for North America Innovative MedicineMale

--

Johnson & Johnson Insider Trades

Date4 Mar
NameHEWSON MARILLYN A
RoleDirector
TransactionAcquired
TypeA-Award
Shares225.768
Date4 Mar
NameWoods Eugene A.
RoleDirector
TransactionAcquired
TypeA-Award
Shares188.14
Date31 Dec
NameWoods Eugene A.
RoleDirector
TransactionDisposed
Type
Shares0
Date25 Feb
NameDecker Robert J
RoleVP Corporate Controller
TransactionAcquired
TypeM-Exempt
Shares6999
Date25 Feb
NameDecker Robert J
RoleVP Corporate Controller
TransactionDisposed
TypeS-Sale
Shares6999
DateNameRoleTransactionTypeShares
4 MarHEWSON MARILLYN ADirectorAcquiredA-Award225.768
4 MarWoods Eugene A.DirectorAcquiredA-Award188.14
31 DecWoods Eugene A.DirectorDisposed0
25 FebDecker Robert JVP Corporate ControllerAcquiredM-Exempt6999
25 FebDecker Robert JVP Corporate ControllerDisposedS-Sale6999

Discover More

Streamlined Academy

Johnson & Johnson

NYSE

Market Cap.

392.42B

Avg. Volume

9.17M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Johnson & Johnson News

Johnson & Johnson Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock

Johnson & Johnson Earnings & Revenue

Johnson & Johnson Income

Johnson & Johnson Balance Sheet

Johnson & Johnson Cash Flow

Johnson & Johnson Financials Over Time

Johnson & Johnson Executives

NameRole
Mr. Joaquin DuatoChief Executive Officer & Chairman
Ms. Jennifer L. TaubertExecutive Vice President & Worldwide Chairman of Innovative Medicine
Dr. John C. Reed M.D., Ph.D.Executive Vice President of Innovative Medicine, R&D
Ahmet Tezel Ph.D.Group Chairman & Global Head of MedTech Innovation and R&D
Mr. Tom CavanaughCompany Group Chairman for North America Innovative Medicine
NameRoleGenderDate of BirthPay
Mr. Joaquin DuatoChief Executive Officer & ChairmanMale19635.9M
Ms. Jennifer L. TaubertExecutive Vice President & Worldwide Chairman of Innovative MedicineFemale19643.16M
Dr. John C. Reed M.D., Ph.D.Executive Vice President of Innovative Medicine, R&D19583.11M
Ahmet Tezel Ph.D.Group Chairman & Global Head of MedTech Innovation and R&D

--

Mr. Tom CavanaughCompany Group Chairman for North America Innovative MedicineMale

--

Johnson & Johnson Insider Trades

Date4 Mar
NameHEWSON MARILLYN A
RoleDirector
TransactionAcquired
TypeA-Award
Shares225.768
Date4 Mar
NameWoods Eugene A.
RoleDirector
TransactionAcquired
TypeA-Award
Shares188.14
Date31 Dec
NameWoods Eugene A.
RoleDirector
TransactionDisposed
Type
Shares0
Date25 Feb
NameDecker Robert J
RoleVP Corporate Controller
TransactionAcquired
TypeM-Exempt
Shares6999
Date25 Feb
NameDecker Robert J
RoleVP Corporate Controller
TransactionDisposed
TypeS-Sale
Shares6999
DateNameRoleTransactionTypeShares
4 MarHEWSON MARILLYN ADirectorAcquiredA-Award225.768
4 MarWoods Eugene A.DirectorAcquiredA-Award188.14
31 DecWoods Eugene A.DirectorDisposed0
25 FebDecker Robert JVP Corporate ControllerAcquiredM-Exempt6999
25 FebDecker Robert JVP Corporate ControllerDisposedS-Sale6999

Streamlined Academy

Website screenshot
HealthcareDrug Manufacturers - General
jnj.com

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Johnson & Johnson

Johnson & Johnson Financials

Table Compare

Compare JNJ metrics with:

   

Earnings & Growth

JNJ

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

JNJ

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

JNJ

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

JNJ

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Johnson & Johnson Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

4.9600

Payment DateDividendFrequency
2025-03-041.24Quarterly
2024-12-101.24Quarterly
2024-09-101.24Quarterly
2024-06-041.24Quarterly
2024-03-051.19Quarterly

Johnson & Johnson Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityBuy
Return on AssetsStrong Buy
Debt/Equity RatioSell
Price/Earnings RatioStrong Sell
Price/Book RatioSell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More

A Practical Guide: How To Analyze Any Stock (With Examples)